Optimization of a direct spectrophotometric method to investigate the kinetics and inhibition of sialidases by Jasvinder Hayre et al.
Hayre et al. BMC Biochemistry 2012, 13:19
http://www.biomedcentral.com/1471-2091/13/19METHODOLOGY ARTICLE Open AccessOptimization of a direct spectrophotometric
method to investigate the kinetics and inhibition
of sialidases
Jasvinder Kaur Hayre1†, Guogang Xu2,3†, Luisa Borgianni1, Garry L Taylor4, Peter W Andrew5,
Jean-Denis Docquier1 and Marco R Oggioni1*Abstract
Backgrounds: Streptococcus pneumoniae expresses three distinct sialidases, NanA, NanB, and NanC, that are
believed to be key virulence factors and thus, potential important drug targets. We previously reported that the
three enzymes release different products from sialosides, but could share a common catalytic mechanism before
the final step of product formation. However, the kinetic investigations of the three sialidases have not been
systematically done thus far, due to the lack of an easy and steady measurement of sialidase reaction rate.
Results: In this work, we present further kinetic characterization of pneumococcal sialidases by using a direct
spectrophotometric method with the chromogenic substrate p-nitrophenyl-N-acetylneuraminic acid (p-NP-Neu5Ac).
Using our assay, the measured kinetic parameters of the three purified pneumococcal sialidase, NanA, NanB and
NanC, were obtained and were in perfect agreement with the previously published data. The major advantage of
this alternative method resides in the direct measurement of the released product, allowing to readily determine of
initial reaction rates and record complete hydrolysis time courses.
Conclusion: We developed an accurate, fast and sensitive spectrophotometric method to investigate the kinetics of
sialidase-catalyzed reactions. This fast, sensitive, inexpensive and accurate method could benefit the study of the
kinetics and inhibition of sialidases in general.
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Sialidases catalyze the removal of terminal sialic acid
residue from various glycoconjugates and have been
implicated in pathogenesis of infectious diseases [1]. In
fact, sialidases differ significantly in kinetic parameters,
substrate specificity and catalytic properties. For ex-
ample, typical sialidases hydrolyze sialiosides to release
N-acetylneuraminic acid (Neu5Ac), whereas the leech
intramolecular (IT) trans-sialidase produces 2,7-anhydro-
Neu5Ac selectively from α2,3- sialosides, while trypanoso-
mal trans-sialidase can also transfer Neu5Ac to another
sugar [2,3].* Correspondence: oggioni@unisi.it
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reproduction in any medium, provided the orThe major human pathogen Streptococcus pneumo-
niae encodes three distinct sialidases, NanA, NanB
and NanC that could be classified into three different
subtypes [4]. According to a recent NMR report,
NanA is a classic hydrolytic sialidase, whereas NanB
could be an IT trans-sialidase similar to the leech en-
zyme, and NanC can handle the dual functions of
both producing 2-deoxy-2,3-didehydro-N-acetylneura-
minic acid (Neu5Ac2en, DANA) and hydrating this
general sialidase inhibitor when substrate is depleted
[5-7]. Nonetheless, it is proposed that the three could
share a common catalytic mechanism before the final
product formation step from a chemistry point of
view. Based on these findings, a new sialidase triad is
speculated, which might coordinate the sialidase action
associated with pneumococcal virulence. However, the
kinetic investigations of the three sialidases have nottd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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an easy and steady measurement of sialidase reaction
rate.
A variety of techniques have been used for the sialid-
ase activity assays, but all present technical challenges.
The classical method is the thiobarbituric acid (TBA)
assay, in which released Neu5Ac reacts with TBA
reagent and shows a specific absorbance measurable at
549 nm [8]. Thin layer chromatography (TLC) is
another method to visualize the sialidase reaction
products [9]. A more sophisticated method has been
described by Trignali et al., which use radiolabelled
gangliosides and high performance TLC separation
of the reaction products [10]. Both methods are
still employed for the sialidase substrate specificity de-
termination. NMR is the best way to characterize the
different sialic acids released, but requires access to
expensive instrumentation [3,11]. In recent years,
two artificial substrates 2’-(4-methylumbelliferyl)-α-D-
N-acetylneuraminic acid (4MU-Neu5Ac) and 2-O-(p-
nitrophenyl)-N-acetylneuraminic acid (p-NP-Neu5Ac)
(Figure 1), were developed for fast sialidase assays [12].
The α-glycosidical linkage of these substrates can
be hydrolyzed by sialidases to release a measurable
fluorescence (4-methylumbelliferone, 4MU) or yellow
product in alkaline conditions (p-nitrophenol, p-NP),
respectively.
To ease the measurement of reaction rates, and on the
basis of the spectral properties of the reaction substrate
(p-NP-Neu5Ac) and product (p-NP), a direct spectro-
photometric method was designed in the current study,
which allows the monitoring of the concentration of the
reaction product as a function of time. In contrast to
previous method, it does not need to stop the reaction
by alkaline buffer before every reading. The kinetic
characterization of NanA, NanB and NanC was
performed, as it could provide further insights into their
roles in pneumococcal virulence and metabolism
[13-16]. The data are in good agreement with previously
obtained NanA, NanB and NanC kinetic parameters,
and followed the first-order reaction kinetics [5,6]. The
anti-influenza drugs Zanamivir and Oseltamivir (inhibi-
tors of influenza virus sialidases) were also tested as
inhibitors of pneumococcal sialidases, in our experimen-
tal setup.Figure 1 The structures of 4MU-Neu5Ac and pNP-Neu5Ac. (a) 4MU-Ne
Formula: C17H22N2O11; MW: 430.36 g/mol.Methods
Cloning, expression and purification of S. pneumoniae
sialidases
The genes nanA (spr1536) and nanB (spr1531) were
cloned from the genomic DNA of S. pneumoniae strain
R6. The third sialidase gene, nanC, which is not present
in R6, so was obtained from TIGR4 pneumococcal DNA
(SP1326). The amplified gene segments were subse-
quently ligated into the commercially-available vectors,
PQE30 (Qiagen), PET23b (Novagen) and PET21b (Nova-
gen), respectively. Recombinant proteins NanA, NanB
and NanC were overexpressed in Escherichia coli sys-
tems and were purified as described previously [5,6,17].
Protein purity was monitored by SDS-PAGE and the
protein identities were confirmed by mass spectrometry.
Sialidase assays and determination of kinetic parameters
The activity of the sialidases was assayed colorimetri-
cally and fluorometrically using the substrates p-NP-
Neu5Ac (Sigma, St. Louis, Miss) and 4MU-Neu5Ac
(Sigma, St- Louis, Miss), respectively. Conventional in-
direct assays were performed as previously described
[5,6,17]. Briefly, the reaction mixtures containing the
substrates and up to 100 nM sialidase were incubated
at 37°C and stopped by the addition of 0.5 M Na2CO3
pH 9.0 for the colorimetric assay or 0.25 M glycine pH
10.0 for the fluorimetric assay. Released p-NP was
detected spectrophometrically at 405 nm. The fluores-
cence associated with the release of 4-MU was mea-
sured at the excitation wavelength of 365 nm and an
emission wavelength of 445 nm. These measurements
were performed using an EnVision microplate reader
(Perkin Elmer, Waltham, Mass.).
An alternative direct spectrophotometric method was
optimized on the basis of the properties of the reaction
substrate p-NP-Neu5Ac and its product p-NP, whose
UV–vis spectra were recorded on a Cary 100 UV–vis
spectrophotometer at 30°C. This method does not need
to stop the reactions with the alkaline buffer and can be
operated easily in multi-well flat-bottom assay plates and
a microplate reader, allowing for a substantial improve-
ment of data throughput. The variation occurring in the
UV-visible spectrum upon hydrolysis of the substrate
was investigated by recording, at different incubation
times, spectra of 200–400 μM of p-NP-Neu5Ac inu5Ac, Formula: C21H24NNaO11; MW: 489.41 g/mol; (b) pNP-Neu5Ac,
Hayre et al. BMC Biochemistry 2012, 13:19 Page 3 of 7
http://www.biomedcentral.com/1471-2091/13/1910 mM MES buffer (pH, 6.0) in the presence of 25–700
nM of purified recombinant NanA.
The kinetic parameters of the various sialidases was
determined at at 30°C in 20 mM MES buffer, pH 6.0.
The initial reaction rates or complete time-course hy-
drolyses were recorded at a fixed wavelength of 400 nm
(ΔεM, 1,300 ± 200 M-1cm-1) in the presence of various
substrate concentrations. Enzyme concentrations were
adjusted to obtain a measurable initial velocity or to rec-
ord the complete reaction time-course (E0 ranged 14 to
140 nM for NanA; 160 to 9,600 nM for NanB; and 100
to 500nM for NanC). Kinetic parameters were computed
using either the direct fit of the initial rates vs [S] data
with the Henri-Michaelis-Menten equation of by analyz-
ing the complete time-course reactions with the inte-
grated form of Henri-Michaelis-Menten equation, as
previously described [18]. Each reaction was repeated at
least three times. The pH and buffer dependencies of
the sialidases NanA, NanB NanC were investigated in
the buffers (Sodium Citrate/Disodim phosphate (100
mM, pH 4.0-5.5) and MES [2-(N-morpholino) ethane-
sulfonic acid] (20 mM, pH 5.5-7.0). Sialidase inhibitors
used in this study, Neu5Ac2en, Zanamivir and Oseltami-
vir carboxylate were obtained from Sigma, Glaxo-
SmithKline and Roche Pharmaceutics respectively.
Inhibition constants (Kis) were computed by measuring
the initial reaction rates in the presence of varying con-
centration of inhibitors, using an competitive inhibition
model, as previously described (20). Alternatively, the
Vmax/Km* value, where Km* =Km(1 + [I]/Ki), was com-
puted from the complete time-course hydrolysis in the
presence of various inhibitor concentrations. The ratio
(Vmax/Km)/( Vmax/Km*) (in the i. e. in the absence andFigure 2 UV–vis spectra of p-NP-Neu5Ac upon hydrolysis by the purif
alone (thick blue line) and after 1 (thin blue line), 2 (dashed blue line), 3 (b
and 15 min (thick red line) incubation in the presence of 100 nM NanA. Th
upon further incubation. Inset. Difference spectrum between intact and hy
appearance of a signal at 400 nm and a red-shift of the main peak from ~3presence of the inhibitor, respectively) was plotted as a
function of [I], yielding a line, whose slope corresponds
to 1/Ki.
Thermal stability assay of sialidase NanA
The thermal shift assay of sialidase NanA against differ-
ent buffers was performed in an iCycler iQ5 Real-Time
PCR Detection System (Bio-Rad, Hercules, CA). In brief,
to each well of a 96-well PCR plate was added 1 μl of 50
μM NanA, 0.25 μl of 500 × Sypro orange protein dye
(originally 5000 × in Dimethyl sulfoxide) and 48.75 μl of
buffer. The final volume was 50 μl. After sealing with
optical film on top, the plate was put into the Real-Time
PCR machine. The plate was then heated from 25°C to
89°C at the heating rate of 0.5°C per min. The fluores-
cence intensity of each well was measured at 490 nm ex-
citation and 530 nm emission wavelength every min.
The thermal shift curves were generated by the iCycler
system automatically.
Results
Optimization of a direct spectrophotometric assay to
investigate the kinetics of sialidase-catalyzed reactions
UV-visible spectra of the substrate and reaction product
of pneumococcal sialidases catalysis were compared in
this work. The production of p-NP resulted in the ap-
pearance of an absorbance signal at 400 nm, an increase
of absorbance at 220 nm and a red-shift of the substrate
peak at ~300 nm to ~315 nm (Figure 2). The difference
spectrum showed that major absorbance variations upon
substrate hydrolysis were observed at 350 and 400 nm.
To readily measure initial reaction rates and record
complete hydrolysis curves, a fixed wavelength of 400ied sialidase NanA. Spectra were recorded for 232 μM pNP-Neu5Ac
lack line), 4 (dashed black line), 5 (green line), 7 (dashed green line)
e reaction was complete after 15 min and the spectra did not change
drolyzed p-NP-Neu5Ac, showing the variation in the spectrum: the
00 to ~315 nm.
Figure 3 Henri-Michaelis-Menten plot for the hydrolysis of p-NP-Neu5Ac by NanA. The normalized initial rates (V0/E0) are plotted as a
function of substrate concentration, showing the perfect agreement between the initial rates measured with the conventional indirect method
(empty circles) and our direct method (black circles). Reactions followed a first-order kinetics. Inset. An example of complete hydrolysis time
course of 116, 232 and 464 μM p-NP-Neu5Ac (dotted, dashed and plain line, respectively) by 100 nM NanA, which allowed to compute the
catalytic efficiency as described by DeMeester et al. [18].
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absorb at this wavelength and (b) it is in the visible
range. The molar variation of the extinction coefficient
was computed from the difference spectrum (ΔEM,
1,300 ± 200 M-1cm-1). . Although the absorbance vari-
ation is lower than with the indirect spectrophotometric
method (the extinction coefficient of p-NP at pH 9.0 is
~18,000 M-1s-1), the final data were in good agreement
with previous NanA, NanB and NanC kinetic results.
The kinetic parameters were computed using the direct
fit of the data (initial reaction rates vs substrate concen-
tration) with the Henri-Michaelis-Menten equation. As
shown Figure 3 and Table 1, it can be seen that all reac-
tions clearly followed first-order kinetics and allowed to
compute the kcat/Km parameter, but not the kcat and Km
values. These kinetic parameters with the direct method
are comparable to those obtained with the conventional
assays carried out previously with the indirect method
[16] (Figure 2, Table 1) and also with the previously pub-
lished NMR kinetic results using α2,3-sialyllactose as a
substrate [6]. Furthermore, the three pneumococcalTable 1 Kinetic parameters for the hydrolysis of p-NP-Neu5Ac
direct and the indirect spectrophotometric assays (see Mater
p-NP-Neu5Ac direct method
kcat (s
-1) Km (μM) kcat/Km (M
-1s-
NanA* >175 >500 (3.5 ± 0.3) × 10
NanB* >0.14 >500 (2.7 ± 0.3) × 10
NanC* >17 >500 (3.4 ± 0.3) × 10
* first order reaction kinetics were observed with this substrate at concentrations u
allowed to compute the kcat/Km values.sialidases present distinct activity: NanA is most active
sialidase among the three, the catalytic efficiency of
which is at least 10 times higher than NanB and NanC
in this assay.
The effects of buffer and pH on the activity of
pneumococcal sialidases
Previously we identified that CHES (2-n-cyclohexyla-
mino ethane sulfonic acid) buffer is a weak inhibitor of
pneumococcal sialidases [5]. In this study, to avoid using
buffers that might affect the enzyme activity, a kinetic
study with some commonly used buffer systems, such as
citric phosphate and MES, and was performed. It was
observed that all the sialidases are active in a wide pH
range from 4–8, but the pH optimum varied slightly
among the three enzymes (NanA 5.5-6.5; NanB 5–5.5;
NanC 5–6, see Figure 4). This finding is also in agree-
ment with the preliminary thermal shift assay screening
results, which showed NanA present higher thermal sta-
bility in MES than in other buffer systems (Figures 5
and 6).by the pneumococcal sialidases computed using the
ials and Methods for details)
p-NP-Neu5Ac indirect method
1) kcat (s
-1) Km (μM) kcat/Km (M
-1s-1)
5 >490 >1,100 (8.4 ± 0.9) × 104
2 >11 >1,200 (1.1 ± 0.1) × 102
4 >11 >700 (1.2 ± 0.1) × 104
p to 500 μM (direct method) or 1,200 μM (indirect method) and thus only
Figure 4 Inhibition of NanA by the sialidase inhibitor Neu5Ac2en. The graph shows the dependence of the (Vmax/Km)/(Vmax/Km*) ratio as a
function of the inhibitor concentration. The Vmax/Km* values were computed from the complete time-course reactions recorded in the presence
of increasing concentrations of inhibitor and using 232 μM p-NP-Neu5Ac as the reporter substrate.
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neuraminidase inhibitors
With our modified method, the inhibition of NanA,
NanB and NanC by the general sialidase inhibitor
Neu5Ac2en and the influenza virus sialidase inhibitors
(Zanamivir and Oseltamivir carboxylate) was readily
investigated. Only Neu5Ac2en and Oseltamivir carboxyl-
ate showed significant inhibition of NanA, with inhib-
ition constants in the micromolar range (Figure 4,
Table 2). Very limited inhibitory effects of NanA were















Figure 5 The buffer/pH effects on the pneumococcal sialidase
activity. The three sialidases NanA (squares), NanB (circles) and
NanC (triangles) showed a variable activity in different buffers
(empty markers, citrate/phosphate buffer; plain markers, MES buffer)
and at pH values ranging from 4–6.5, with optimum pHs which
varied slightly among the three enzymes (NanA 5.5-6.5; NanB 5–5.5;
NanC 5–6). These data, measured with either the fluorogenic
substrate 4MU-Neu5Ac or the chromogenic substrate p-NP-Neu5Ac,
gave comparable results.poorly or not inhibited by the three sialidase inhibitors.
These findings are in good agreement with previous
reports [19].
Discussion
Sialidases play a key role in infections caused by several
microbial pathogens including influenza virus, parainflu-
enza virus and S. pneumoniae [1]. Therefore, a reliable,
fast, simple, inexpensive and accurate kinectic method
would be of advantage for characterizing the potential
inhibitors or pro-drugs for sialidases, a major target for
drug redevelopment [1]. Indeed, although the classical
TBA and TLC are useful in providing key information
regarding substrate specificity, these assays have major
drawbacks represented by the complicated experimental







30 40 50 6 70 80 90
Temperature (°C)
Figure 6 The thermal shift assay of NanA in seven different
buffers. The melting curves of NanA undergo unfolding with the
increasing of temperature in the tested buffers (Red Acetate, Orange
MOPS, Blue Phosphate, Green MES, Cyan HEPES, Black Tris-Cl, and
Purple Imidazole). MES buffer (Green line) confers the optimal
sialidase thermal stability for NanA.
Table 2 Inhibition assay of pneumococcal sialidases
Ki (μM)
Neu5Ac2en Oseltamivir carboxylate Zanamivir
NanA 1.6 1.77 720
NanB 330 -* -*
NanC 2,010 -* -*
*-, no inhibition observed with inhibitor concentrations up to 7,500 μM.
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spectroscopy, would be perfect to detect small-molecule
interactions and determine the final product, but needs
a high-profile NMR facility and large amount of sub-
strates and enzymes, as well as well-trained NMR
personnel [11,20]. Therefore, most researchers preferred
using the artificial substrates 4MU-Neu5Ac or p-NP-
Neu5Ac for sialidase enzyme kinetics. When the α-
glycosidical linkage is hydrolyzed by sialidases, the
reactions will be stopped by adding some extreme pH
buffer and the leaving groups 4MU or p-NP can be
quantified by fluorimetry or spectrophotometry respect-
ively. 4MU-Neu5Ac is relatively expensive and is prone
to degradation at room temperature. Furthermore, the
presence of Neu5Ac2en can interfere with the fluores-
cence reading of 4MU. Therefore, we focused on the
modification of the p-NP-Nue5Ac method to establish a
better approach for sialidase enzyme kinetics.
Here, with both 4MU-Neu5Ac and p-NP-Neu5Ac si-
alidase assays and our direct spectrophotometric
method, we observed that NanA, NanB and NanC show
different pH optima and the activity could be affected by
the buffer systems. It is intriguing that phosphate buffer
at neutral pH has some negative effects on the NanATable 3 Comparisons of existing sialidase assay methods
TBA assay TLC Radiochemical
method
Substrates Sialosides Sialosides Sialosides




Instruments Spectrometer TLC plate HPTLC and
radiochromatoscanner
Time to run hours hours hours
Safety issue 5TC toxic Hazardous in case
of skin contact
Radioactive substrate
Automation No No No









Not applicable Costly; Time
consuming
Reference(s) [8] [9] [10]and NanC activity, but not NanB. By contrast, the three
sialidases shower higher enzymatic activity in MES buf-
fer, pH 5.5. Preliminary thermal shift assays confirmed
that MES could increase the thermal stability of the
sialidase.
In the present study, we also investigated the typical
sialidase inhibitors Neu5Ac2en, Oseltamivir carboxylate
and Zanamivir. Unlike the influenza virus sialidases,
NanA is the only enzyme among the three pneumococ-
cal sialidases that could be inhibited by Neu5Ac2en and
Oseltamivir carboxylate with inhibition constants in the
micromolar range [19]. Very limited inhibitory effects
of NanA were seen with Zanamivir. None of the tested
inhibitors significantly inhibited NanB and NanC
(Ki > > 7.5 mM). Previous structural studies had indi-
cated that the guanidinium group of Zanamivir does
not add to substrate-NanA interactions, which is differ-
ent from the binding pattern of influenza virus neur-
aminidase and could be the reason why Zanamivir is a
weak inhibitor to NanA [19]. Similar results were also
observed in animal studies [14]. Furthermore, compari-
son of NanA complexes with NanB structures and
NanC model shows that both Zanamivir and Oseltami-
vir cannot interact tightly with the other pneumococcal
sialidases due to the different architecture around active
sites [19].
Conclusions
In this work, we developed an accurate, fast and sensi-
tive spectrophotometric method to investigate the kinet-
ics of sialidase-catalyzed reactions. Using our assay, the
measured kinetic parameters of the three purified




Sialosides Sialosides 4MU-Neu5Ac pNP-Neu5Ac
Deuterated
buffer
Malonitrile Normal buffer Normal buffer
NMR facility HPLC and
fluorimeter
Fluorimeter Spectrophotometer
















[3,11] [20] [7,12,16] [12]
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ously published data [5-7]. In view of the fact that both
the substrates used in this paper, as also the relative
inhibitors work well, and were in fact originally devel-
oped, for assays of viral sialidases, the method developed
should be suitable for the assays of most sialidases, in-
cluding most if not all viral and bacterial sialidases
[21,22]. This method, prone to automation and high-
throughput screening, could ease and accelerate the
screening of potential large libraries of chemical com-
pounds to identify new inhibitors, which represent inter-
esting and relevant anti-infective drug targets.
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